Synonym: 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
CAS Number: 155213-67-5
Empirical Formula (Hill Notation): C37H48N6O5S2
Molecular Weight: 720.94
Linear Formula: C37H48N6O5S2
Product Type: Chemical
| agency |
EP |
| application(s) |
pharmaceutical (small molecule) |
| biological source |
synthetic |
| format |
neat |
| grade |
pharmaceutical primary standard |
| InChI |
1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 |
| InChI key |
NCDNCNXCDXHOMX-XGKFQTDJSA-N |
| manufacturer/tradename |
EDQM |
| packaging |
pkg of 80 mg |
| shipped in |
ambient |
| solubility |
ethanol: soluble |
| |
methanol: soluble |
| storage condition |
protect from light |
| storage temp. |
2-8°C |
| Application: |
Ritonavir may be used as a pharmaceutical primary standard for the quantification of the analyte in pharmaceutical formulations using chromatography techniques. |
| Caution: |
Please find SDS provided by EDQM here.   . |
| General description: |
Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles. |
| Other Notes: |
Sales restrictions may apply. |
| Packaging: |
Unit quantity: 80 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
| Storage Temp. |
2-8°C |
| UNSPSC |
41116107 |
GHS07